<
https://theconversation.com/new-malaria-vaccine-proves-highly-effective-and-covid-shows-how-quickly-it-could-be-deployed-159585>
"Coronavirus vaccines have been developed and deployed in record time, but as
global rollout has progressed, too few doses have been made available in
low-income countries. It’s a stark reminder that when it comes to infectious
diseases, the world’s poorest often get left behind.
This is a problem that extends far beyond COVID-19. In Africa, for example,
malaria has probably caused four times as many deaths as COVID-19 over the past
year. Thankfully, our new research shows that an effective vaccine against
malaria could now be closer than ever before.
For the first time, a vaccine has shown high efficacy in trials – preventing
the disease 77% of the time among those receiving it. This is a landmark
achievement. The WHO’s target efficacy for malaria vaccines is over 75%. Until
now, this level has never been reached.
The speed and success of developing COVID-19 vaccines shows what’s possible,
and should be an inspiration to get this malaria vaccine finished, licensed and
distributed. It’s important not just because of the threat malaria poses, but
also because investing in vaccines can help prepare us for the next pandemic.
Work on this vaccine helped speed the development of the Oxford vaccine for
COVID-19 as well."
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
